HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature.

Abstract
Scleredema (also called scleredema of Buschke) is a fibromucinous connective tissue disorder of unknown cause that belongs to a group of scleroderma-like disorders. We report the case of a 64-year-old lady with long-standing scleredema, associated with a paraprotein, and progressing to multiple myeloma and AL amyloidosis. The relationship of scleredema with paraprotein and multiple myeloma is well established, but only two cases of scleredema associated with amyloidosis have been reported to date. We suggest that amyloidosis may be underdiagnosed in patients with scleredema and paraproteinaemia. Features attributed to extracutaneous manifestations of scleredema could represent systemic amyloidosis. We review published reports of scleredema associated with paraprotein and discuss the difficulties in the differential diagnosis of scleroderma-like disorders. We discuss the diagnosis of plasma cell dyscrasias and amyloidosis and their relevance in rheumatology practice.
AuthorsMagdalena Dziadzio, Constantinos P Anastassiades, Philip N Hawkins, Michael Potter, Armando Gabrielli, Geraldine M Brough, Carol M Black, Christopher P Denton
JournalClinical rheumatology (Clin Rheumatol) Vol. 25 Issue 1 Pg. 3-15 (Feb 2006) ISSN: 0770-3198 [Print] Germany
PMID15742120 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Amyloidosis (etiology, pathology)
  • Disease Progression
  • Female
  • Humans
  • Middle Aged
  • Multiple Myeloma (etiology, pathology)
  • Paraproteinemias (complications, pathology)
  • Scleredema Adultorum (complications, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: